{
    "symbol": "TMDI",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-12 11:03:05",
    "content": " Many factors could cause the company's actual results, performance, or achievements to be materialloy different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including without limitation, those listed in the caution regarding forward-looking statements and risk factors section of the company's annual report on Form 20-F for the fiscal year ended December 31, 2021, which may be viewed at cedar.com and at sec.gov. In the quarter, the company's R&D expenses were focused on finishing product development and transferring key components of the Enos system to manufacturing in the comparative period, R&D expenses related to the development of the Enos system and the development work required to achieve the milestones under the development agreement with Medtronic."
}